Quality assurance of stem cell enumeration by flow cytometry

Communications in Clinical Cytometry

Volumn 30, Issue 6, 1997, Pages 296-303

  Chin Yee, I ^a,c   Anderson, L ^a,c   Keeney, M ^a,c   Sutherland, D R ^b   Bakkestad Legare, P ^d   Chadderton, T ^e   Chan, A ^b   Chopra, A ^d   D'Angelo, J ^f   Delage, R ^g   Lee, S F ^h   Lim Yin, J ⁱ   Luider, J ^j   Klassen, J ^j   Mansour, S ^k   Neame, P B ^l   Soamboonsrup, P ^l   Noel D ^m   Robinson, J ⁿ   Sicilia, F ^o   Sutherland, R ^b   Tsang, A ^p   Webster, L A ^q   Wright, Margaret ^r   more..

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d Canadian Red Cross Society   (Canada)

^e Northeastern Ontario Regional Cancer Centre   (Canada)

^f MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^g LAVAL UNIVERSITY   (Canada)

^h UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j FOOTHILLS HOSPITAL   (Canada)

^k CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^l HAMILTON GENERAL HOSPITAL   (Canada)

^m HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

ⁿ SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^o MCGILL UNIVERSITY   (Canada)

^p BC CHILDREN S HOSPITAL   (Canada)

^q PRINCESS MARGARET HOSPITAL   (Canada)

^r QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

more..

Author keywords

CD34; Hematopoietic stem cells; Quality assurance; Standardization

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN;

ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FLOW CYTOMETRY; GOOD LABORATORY PRACTICE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; QUALITY CONTROL; STANDARD; STEM CELL TRANSPLANTATION;

EID: 0008929019     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19971215)30:6<296::AID-CYTO5>3.0.CO;2-E     Document Type: Article

References (20)

1. Brecher M, Sims L, Schmitz J, Shea T, Bentley SJ: North American multicenter study on flow cytometric enumeration of CD34+ hematopoietic stem cells. J Hematother 5:227-236, 1996.
2. Broxmeyer HE, Douglas GW, Hangoc G, et al.: Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86:3828-3832, 1989.
3. Center for Disease Control: 1995 revised guidelines for the performance of CD4+ T-cell determinations in persons with Human Immunodeficiency Virus (HIV) infection. MMWR 43:1-21, 1994.
4. Chang A, Ma DDF: The influence of flow cytometric gating strategies on the standardisation of CD34+ cell quantitation: An Australian multi-centre study. J Hematother 5:605-616, 1996.
5. Civin C., Trischman T, Fackler MJ, Bernstein I, Buhring H, Campos L, Greaves MF, Kamoun M, Katz D, Lansdorp P, Look T, Seed B, Sutherland DR, Tindle R, Uchanska-Zeigler B: Summary of CD34 cluster workshop section. In: Leucocyte Typing IV, Knapp W et al. (eds). Oxford Univ Press, Oxford (N), 1989.
6. Henon PR: Peripheral blood stem cell transplantation: Past, present and future. Stem Cells 11:154-172, 1993.
7. Johnsen HE: Report from a Nordic workshop on CD34+ cell analysis: Technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. J Hematother 4:21-28, 1995.
8. Johnsen HE, Knudsen LM, for the Nordic Stem Cell Laboratory Group (NSCL-G): Nordic flow cytometry standards for CD34+ cell enumeration in blood and leukapheresis products: Report from the Second Nordic Workshop. J Hematother 5:237-245, 1996.
9. Lowdell MW, Bainbridge DR: External quality assurance for CD34 cell enumeration - results of a preliminary national trial. Royal Microscopical Society Clinical Flow Cytometry Group QA Schemes. Bone Marrow Transplant 5:849-853, 1996.
10. Russell NH, Hunter A, Rogers S, et al.: Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 341: 1482, 1993.
11. Siena S, Bregni M, Brando B, Ravignani F, Bonadonna G, Gianni AM: Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74:1905-1914, 1989.
12. Siena S, Bregni M, Belli N, et al.: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400-409, 1991.
13. Siena S, Bregni M, DiNicola M, et al. In: Hematopoietic Stem Cells: The Mulhouse Manual. Wunder E, Sovolat H, Henon PR, Serke S (eds). Dayton, OH: Alphamed Press, 1994, p 23.
14. Smith A, Keating A (eds): Peripheral Blood Progenitor Cell Transplantation: Clinical, Technical and Economic Considerations, vol 3, J. Hematotherapy, 1994.
15. Stewart AK, Imrie K, Keating A, Anania S, Nayar R, Sutherland DR: Optimizing the CD34+ Thy-1+ stem cell content of peripheral blood collections. Exp Hematol 23:1619-1627, 1995.
16. Sutherland DR, Keating A: The CD34 antigen: Structure, biology and potential clinical applications. J Hematother 1:115-129, 1992
17. Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK: Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 22:1003-1010, 1994.
18. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I: The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 5:213-226, 1996.
19. Sutherland R, Anderson L, Keeney M, Nayar R, Chin-Yee I: Re: Towards a worldwide standard for CD34+ enumeration? (Letter). J Hematother 6:85-89, 1997.
20. Wunder E, Sovolat H, Fritsch G, Silvestri F, Henon P, Serke S: Report on the European workshop on peripheral blood stem cell determination and standardisation - Mulhouse, France. J Hematother 1:131-142, 1992.